Atlas Trials

Dose-dense (Biweekly) Carboplatin Plus Paclitaxel With or Without Trastuzumab as Neoadjuvant Treatment for Breast Cancer

Clinical trial NCT02059876 · UNKNOWN

Trial details

NCT number
NCT02059876
Sponsor
Guangdong Provincial People's Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2013-11-01
Primary completion
2014-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.